Cargando…
Pancreatic β‐cell fate in subjects with COVID‐19
Two recent reports denoted the potential of SARS‐CoV‐2 to directly infect β‐cells and the possible fate of β‐cells under COVID‐19. The fight against SARS‐CoV‐2 will continue to develop more effective therapeutic strategies for diabetes. [Image: see text]
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668054/ https://www.ncbi.nlm.nih.gov/pubmed/34529355 http://dx.doi.org/10.1111/jdi.13671 |
| _version_ | 1784614488942575616 |
|---|---|
| author | Shirakawa, Jun |
| author_facet | Shirakawa, Jun |
| author_sort | Shirakawa, Jun |
| collection | PubMed |
| description | Two recent reports denoted the potential of SARS‐CoV‐2 to directly infect β‐cells and the possible fate of β‐cells under COVID‐19. The fight against SARS‐CoV‐2 will continue to develop more effective therapeutic strategies for diabetes. [Image: see text] |
| format | Online Article Text |
| id | pubmed-8668054 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86680542021-12-21 Pancreatic β‐cell fate in subjects with COVID‐19 Shirakawa, Jun J Diabetes Investig Commentaries Two recent reports denoted the potential of SARS‐CoV‐2 to directly infect β‐cells and the possible fate of β‐cells under COVID‐19. The fight against SARS‐CoV‐2 will continue to develop more effective therapeutic strategies for diabetes. [Image: see text] John Wiley and Sons Inc. 2021-09-27 2021-12 /pmc/articles/PMC8668054/ /pubmed/34529355 http://dx.doi.org/10.1111/jdi.13671 Text en © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Commentaries Shirakawa, Jun Pancreatic β‐cell fate in subjects with COVID‐19 |
| title | Pancreatic β‐cell fate in subjects with COVID‐19 |
| title_full | Pancreatic β‐cell fate in subjects with COVID‐19 |
| title_fullStr | Pancreatic β‐cell fate in subjects with COVID‐19 |
| title_full_unstemmed | Pancreatic β‐cell fate in subjects with COVID‐19 |
| title_short | Pancreatic β‐cell fate in subjects with COVID‐19 |
| title_sort | pancreatic β‐cell fate in subjects with covid‐19 |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668054/ https://www.ncbi.nlm.nih.gov/pubmed/34529355 http://dx.doi.org/10.1111/jdi.13671 |
| work_keys_str_mv | AT shirakawajun pancreaticbcellfateinsubjectswithcovid19 |